BioRestorative Therapies
BRTX | NASDAQ
$1.37
-$0.12 (-8.05%)
At close: Nov 16, 2026, 3:59 PM ET
$1.39
+$0.02 (+1.46%)
After-hours:
Nov 16, 2026, 7:58 PM ET
-8.05%
(1D)No price chart data available for 1D timeframe.
Rating
38.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #556/1021 (Top 54%)
Key Statistics
Market Data
Market Cap $1.89M
1D Range
1.37 1.53
52W Range
1.36 28.60
Valuation (TTM)
PE -0.06
PB 0.63
EV/EBITDA 0.15
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -628.8%
SBC Adj. FCF Yield -713.7%
SBC Impact -13.5%
Margins
Gross Margin 92.1%
Operating Margin -3975.0%
FCF Margin -3324.6%
Growth (CAGR)
Revenue 3Y | 5Y 38.4% |
39.0%
Dil EPS 3Y | 5Y 2.0% |
68.3%
FCF 3Y | 5Y -28.6% |
-22.1%
Returns
ROA -238.3%
ROE -423.8%
ROIC -464.9%
Financial Health
Net Cash
$3.56M
Current Ratio 2.35
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address t...
Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Dec 5, 2012
Website www.biorestorative.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BRTX